Gulshan Polyols Ltd
GULPOLYGulshan Polyols Ltd is coiled. The quarters are improving, yet the P/E sits at the 2nd percentile of its own 11-year range — the business is moving before the market.
The sharpest disagreement: annual EPS moved +332.7% against a +8.2% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (21 weeks in) while the P/E sits at the 2nd percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +315.4% year on year, and 210% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Gulshan Polyols Ltd trades at ₹175, in a confirmed uptrend and 21 weeks into that stage. That is −2.1% against its own 200-day average. It sits at 55% of a 52-week range of ₹126 to ₹215. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (7 weeks and counting).
Today the stock is in a confirmed uptrend — week 21 of stage 2, confirmed. At ₹175 it trades −2.1% versus its 200-day average and sits at 55% of its 52-week range (₹126–₹215).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +230% while the NIFTY 500 moved +259% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-07-24) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Gulshan Polyols Ltd trades at 7.4× P/E, about the cheapest it has ever traded. Its long-run median P/E is 15.8×, measured across 10.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 7.4× is about the cheapest it has ever traded, against a long-run median of 15.8× measured over 10.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +332.7% against a +8.2% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −3.5%/yr price move, ~+9.9%/yr came from earnings growth and ~−13.4 pp from the multiple (compressing); over 10y, of the +11.4%/yr price move, ~+16.1%/yr came from earnings growth and ~−4.7 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 13 June 2026 price, Gulshan Polyols Ltd was paying for profit growth of about 20.8% a year. Profit itself has compounded 13.6% a year over the past 10 years. Today the market pays 7.4× P/E, the 2nd percentile of its own 11-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is above what this company has actually delivered. A multiple that looks low because earnings fell is not the same thing as a low bar to clear.
How to hold this number: it is a reading of one day's price, taken on 13 June 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Gulshan Polyols Ltd reads as improving on its fundamental arc. Improving — EPS growth bottomed 8 quarters ago at −42.0% and has held its recovery at +420.9%, ROCE lifting at 19.0%. The read is built from 9 quarters across 4 curves, on partial evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.5% | +25.1% | +24.7% | +18.2% |
| Profit | +328.0% | +33.5% | +11.5% | +13.6% |
| EPS | +332.7% | +33.2% | +9.1% | +12.1% |
| Share price | +8.2% | −7.8% | −3.5% | +11.4% |
4-Factor Sector Score
70.7/100 — rank 1 of 36 in Miscellaneous · 87% evidence confidence
Gulshan Polyols Ltd scores 70.7 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 1. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 27.5 + 19.2 + 13.2 + 10.8 = 70.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Gulshan Polyols Ltd reported ₹640 Cr of revenue in the Jun 26 quarter, +7.9% year on year. That is the 12th straight quarter of year-on-year growth. Over 10 years it has compounded at 18.2% a year. The last full year, FY26, came in at ₹2,312 Cr. The last four reported quarters add to ₹2,360 Cr.
FY26 revenue came in at ₹2,312 Cr (+14.5% on the year), capping 10 years at 18.2% compound. The latest quarter (Jun 26) printed ₹640 Cr, +7.9% year on year — the 12th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +10.2% growth against the decade's 18.2% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +9.4% over the last 4 quarters against +23.8%/yr over the last 8 — rolling over; TTM profit +432.1% vs +154.5%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Gulshan Polyols Ltd's operating margin is 13.0% in the Jun 26 quarter, +7.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 4.2% to 17.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 13.0%, +7.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 4.2%–17.0%.
Why the margin moved: operating margin went +7.1 pp year on year while gross margin went +9.2 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Gulshan Polyols Ltd earned ₹54.0 Cr of net profit in the Jun 26 quarter, +315.4% year on year. It is the 7th consecutive quarter of growth. Full-year FY26 profit was ₹107 Cr. The 10-year compound rate is 13.6%. That is 8.4% of the quarter's revenue. The same quarter a year earlier earned ₹13.0 Cr.
Jun 26 profit was ₹54.0 Cr, +315.4% year on year — the 7th consecutive quarter of growth. On the full year, FY26 printed ₹107 Cr (+328.0%), and the 10-year compound rate is 13.6%.
Why profit moved: revenue contributed +7.9% and the margin +7.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +686.0% vs revenue +10.2%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 210% of Gulshan Polyols Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹207 Cr of operating cash against ₹107 Cr of profit. After ₹26.0 Cr of capital spending, ₹181 Cr was left as free cash.
FY26: operating cash of ₹207 Cr against reported profit of ₹107 Cr, leaving free cash of ₹181 Cr after ₹26.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 210% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 210%: the cash cycle tightened 32 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 2.3× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Gulshan Polyols Ltd's cash conversion cycle runs 48 days in FY26, down from 80 days in FY21. Capital spending ran ₹260 Cr over the last 3 years. At FY26 sales of ₹2,312 Cr each day of that cycle holds about ₹6.3 Cr, so roughly ₹304 Cr sits inside the business at any moment.
FY26: debtors at 32 days, inventory at 53 days — roughly 1.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 48 days, tighter than FY21's 80.
The full loop: cash goes out to suppliers and production on day 0; stock waits 53 days to sell; customers pay about 32 days after that; and suppliers themselves are paid at 38 days — netting out to the 48-day cycle.
In money terms: at FY26 sales of ₹2,312 Cr, each day of the cycle holds about ₹6.3 Cr — so the 48-day loop keeps roughly ₹304 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹260 Cr over the last 3 fiscal years against ₹114 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹7.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Gulshan Polyols Ltd earns a ROCE of 19% in FY26. That is up from a trough of 3% in FY24. Return on invested capital clears the cost of that capital by +1.1 percentage points, so growth here adds value rather than only size. The wiring behind it is 4.6% net margin on 1.77× asset turns.
FY26 ROCE is 19%, recovered from a FY24 trough of 3% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 4.6% net margin × 1.77× asset turns × 1.82× balance-sheet leverage ≈ 14.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 13.1% − 12.0% = a +1.1 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Gulshan Polyols Ltd carries total debt of ₹313 Cr against shareholder equity of ₹719 Cr as of Mar 26, a debt-to-equity of 0.44. On the annual view that ratio went from 0.22 in FY22 to 0.44 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹313 Cr against shareholder equity of ₹719 Cr — a debt-to-equity of 0.44. On the annual view, debt-to-equity went from 0.22 (FY22) to 0.44 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Gulshan Polyols Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.3 points over the same window, to 0.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: −0.4 points over 8 quarters to 0.0%; Foreign institutions: +0.3 points over 8 quarters to 0.3%; Promoters: +0.1 points over 8 quarters to 66.8%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Gulshan Polyols Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gulshan Polyols Ltdthis pageGULPOLY | 70.7/100Favorable setup87% evidence | ASLEEP | 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence | 19.2/25 ROCE 18.6% · OPM 13% 95% evidence | 13.2/20 P/E 7.4× · PEG — 50% evidence | 10.8/20 RS sector 3.7% · RS bench 7% · 1Y 8.8%5 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 19.2 + 13.2 + 10.8 = 70.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Sagility LtdSAGILITY | 67.6/100Favorable setup87% evidence | TURNING | 24.7/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.8/25 ROCE 13.4% · OPM 22% 100% evidence | 13.5/20 P/E 20.6× · PEG 1.08 65% evidence | 13.6/20 RS sector 7.2% · RS bench 1.7% · 1Y 5.3%3 of 10 weeks ahead 70% evidence |
| Exact sum: 24.7 + 15.8 + 13.5 + 13.6 = 67.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3IIRM Holdings India Ltd526530 | 64.2/100Mixed-positive evidence75% evidence | LEADER | 16.3/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence | 19.0/25 ROCE 20.4% · OPM 24.6% 76% evidence | 9.9/20 P/E 39.9× · PEG — 15% evidence | 19.0/20 RS sector 42.8% · RS bench 47.3% · 1Y 79.1%11 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 19 + 9.9 + 19 = 64.2 · Decision use: Price leads the evidence: RS versus the benchmark is 47.3%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Exhicon Events Media Solutions Ltd543895 | 63.7/100Thin evidence · provisional60% evidence | TURNING | 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.1/25 ROCE 29.5% · OPM 28% 76% evidence | 13.4/20 P/E 19.2× · PEG — 50% evidence | 11.2/20 RS sector 2.2% · RS bench -1.9% · 1Y -4.8%2 of 10 weeks ahead 70% evidence |
| Exact sum: 19 + 20.1 + 13.4 + 11.2 = 63.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Aeroflex Enterprises LtdAEROENTER | 62.8/100Mixed-positive evidence87% evidence | LEADER | 19.7/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence | 14.9/25 ROCE 12.6% · OPM 9% 95% evidence | 9.0/20 P/E 10.2× · PEG — 50% evidence | 19.2/20 RS sector 38.8% · RS bench 42.9% · 1Y 57.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 14.9 + 9 + 19.2 = 62.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Global Education LtdGLOBAL | 62.5/100Mixed-positive evidence80% evidence | TURNING | 14.2/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence | 19.8/25 ROCE 29.2% · OPM 41% 95% evidence | 10.1/20 P/E 24.8× · PEG — 15% evidence | 18.4/20 RS sector 32.4% · RS bench 36.9% · 1Y 97.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 19.8 + 10.1 + 18.4 = 62.5 · Decision use: Price leads the evidence: RS versus the benchmark is 36.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Take Solutions LtdTAKE | 58.7/100Thin evidence · provisional57% evidence | 24.7/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence | 8.5/25 ROCE 11.2% · OPM — 80% evidence | 8.5/20 P/E 3222× · PEG — 15% evidence | 17.0/20 RS sector 71.1% · RS bench 71.4% · 1Y 300.4%11 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 24.7 + 8.5 + 8.5 + 17 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8R K Swamy LtdRKSWAMY | 57.1/100Mixed-positive evidence65% evidence | 22.5/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence | 15.6/25 ROCE 12.3% · OPM 10.4% 95% evidence | 10.7/20 P/E 19.5× · PEG — 15% evidence | 8.3/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead to 2026-08-16 25% evidence | |
| Exact sum: 22.5 + 15.6 + 10.7 + 8.3 = 57.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Aegis Vopak Terminals LtdAEGISVOPAK | 55.8/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.9/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence | 13.2/25 ROCE 7.6% · OPM 77% 76% evidence | 8.9/20 P/E 121× · PEG — 15% evidence | 11.8/20 RS sector — · RS bench 25.5% · 1Y 24.5%10 of 10 weeks ahead 25% evidence |
| Exact sum: 21.9 + 13.2 + 8.9 + 11.8 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Parin Enterprises LtdPARIN | 52.2/100Mixed-positive evidence63% evidence | FADING | 19.4/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.6/25 ROCE 10.8% · OPM 9% 95% evidence | 9.1/20 P/E 117× · PEG — 15% evidence | 12.1/20 RS sector 5.1% · RS bench 8.7% · 1Y 46.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.6 + 9.1 + 12.1 = 52.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Eveready Industries India LtdEVEREADY | 50.9/100Mixed-positive evidence94% evidence | TURNING | 18.9/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence | 13.6/25 ROCE 17.2% · OPM 15% 100% evidence | 9.0/20 P/E 16.6× · PEG 2.1 100% evidence | 9.4/20 RS sector -9.5% · RS bench 8.6% · 1Y -22.3%6 of 10 weeks ahead 70% evidence |
| Exact sum: 18.9 + 13.6 + 9 + 9.4 = 50.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12GMR Airports LtdGMRAIRPORT | 50.8/100Mixed-positive evidence74% evidence | ASLEEP | 22.7/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence | 11.3/25 ROCE 11.6% · OPM 37% 100% evidence | 8.7/20 P/E 184× · PEG — 15% evidence | 8.1/20 RS sector -2.8% · RS bench 0.5% · 1Y 14%6 of 12 weeks ahead 100% evidence |
| Exact sum: 22.7 + 11.3 + 8.7 + 8.1 = 50.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Anzen India Energy Yield Plus TrustANZEN | 50.3/100Mixed-positive evidence60% evidence | TURNING | 20.7/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence | 9.1/25 ROCE 3.3% · OPM 80% 76% evidence | 9.3/20 P/E 99.7× · PEG — 15% evidence | 11.2/20 RS sector — · RS bench 7.3% · 1Y 8.7%1 of 10 weeks ahead 25% evidence |
| Exact sum: 20.7 + 9.1 + 9.3 + 11.2 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Jai Corp LtdJAICORPLTD | 48.3/100Mixed-negative evidence74% evidence | BASING | 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence | 11.4/25 ROCE 11.8% · OPM 15% 95% evidence | 10.9/20 P/E 17.8× · PEG — 15% evidence | 6.4/20 RS sector -8.2% · RS bench -19.2% · 1Y -40.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 19.6 + 11.4 + 10.9 + 6.4 = 48.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Inox Green Energy Services LtdINOXGREEN | 48.0/100Mixed-negative evidence75% evidence | ASLEEP | 22.2/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence | 9.1/25 ROCE 8.4% · OPM -2.2% 76% evidence | 9.7/20 P/E 58.4× · PEG — 15% evidence | 7.0/20 RS sector -6% · RS bench -2.9% · 1Y 19.3%5 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 9.1 + 9.7 + 7 = 48 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16TCC Concept LtdTCC | 47.5/100Mixed-negative evidence81% evidence | BASING | 16.6/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.8/25 ROCE 5.7% · OPM 36% 95% evidence | 14.1/20 P/E 20× · PEG — 50% evidence | 5.0/20 RS sector -17.6% · RS bench -31.9% · 1Y -89.7%0 of 11 weeks ahead 70% evidence |
| Exact sum: 16.6 + 11.8 + 14.1 + 5 = 47.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Prozone Realty LtdPROZONER | 46.4/100Mixed-negative evidence80% evidence | TURNING | 17.0/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence | 6.4/25 ROCE -1% · OPM -35.6% 95% evidence | 9.6/20 P/E 62.1× · PEG — 15% evidence | 13.4/20 RS sector -0.3% · RS bench 3.1% · 1Y 21.7%1 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 6.4 + 9.6 + 13.4 = 46.4 · Decision use: Price leads the evidence: RS versus the benchmark is 3.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 18Aqylon Nexus LtdAQYLON | 45.9/100Mixed-negative evidence72% evidence | BASING | 18.5/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence | 18.8/25 ROCE 131% · OPM 58% 95% evidence | 8.6/20 P/E 759× · PEG — 15% evidence | 0.0/20 RS sector -76.3% · RS bench -75.3% · 1Y -79.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 18.8 + 8.6 + 0 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Jindal Photo LtdJINDALPHOT | 43.3/100Mixed-negative evidence77% evidence | ASLEEP | 20.4/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence | 10.1/25 ROCE -1.4% · OPM 98% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 2.8/20 RS sector -19.1% · RS bench -16.2% · 1Y -14.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 10.1 + 10 + 2.8 = 43.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Shipping Corporation of India Land & Assets LtdSCILAL | 42.8/100Mixed-negative evidence80% evidence | BASING | 24.2/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence | 5.0/25 ROCE 1.3% · OPM -14% 95% evidence | 9.5/20 P/E 62.3× · PEG — 15% evidence | 4.1/20 RS sector -17.6% · RS bench -14.8% · 1Y -26.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 5 + 9.5 + 4.1 = 42.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17.6% and the one-year return is -26.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 21TruAlt Bioenergy LtdTRUALT | 40.3/100Mixed-negative evidence63% evidence | ASLEEP | 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.3/25 ROCE 10.4% · OPM 21% 100% evidence | 10.3/20 P/E 22.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -21.6%2 of 12 weeks ahead 0% evidence |
| Exact sum: 10.7 + 9.3 + 10.3 + 10 = 40.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22GKW LtdGKWLIMITED | 39.2/100Mixed-negative evidence71% evidence | ASLEEP | 10.9/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence | 9.2/25 ROCE 0.5% · OPM 84% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector -0.9% · RS bench -4.5% · 1Y -9.4%2 of 10 weeks ahead 70% evidence |
| Exact sum: 10.9 + 9.2 + 10 + 9.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Unitech LtdUNITECH | 36.8/100Mixed-negative evidence69% evidence | BASING | 18.0/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence | 3.5/25 ROCE 0.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 5.3/20 RS sector -22.3% · RS bench -19.7% · 1Y -39.9%2 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 3.5 + 10 + 5.3 = 36.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Kaveri Seed Company LtdKSCL | 35.9/100Mixed-negative evidence94% evidence | BASING | 11.3/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence | 14.4/25 ROCE 18.8% · OPM 40% 100% evidence | 4.7/20 P/E 14.8× · PEG 3.12 100% evidence | 5.5/20 RS sector -17.2% · RS bench -19.8% · 1Y -40%1 of 11 weeks ahead 70% evidence |
| Exact sum: 11.3 + 14.4 + 4.7 + 5.5 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Delta Corp LtdDELTACORP | 35.4/100Mixed-negative evidence81% evidence | BASING | 9.7/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence | 8.6/25 ROCE 5.1% · OPM 18% 95% evidence | 12.0/20 P/E 9.4× · PEG — 50% evidence | 5.1/20 RS sector -18.1% · RS bench -18.3% · 1Y -36.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 8.6 + 12 + 5.1 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Stanley Lifestyles LtdSTANLEY | 30.0/100Adverse evidence74% evidence | BASING | 6.6/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence | 10.8/25 ROCE 6.4% · OPM 17.3% 95% evidence | 9.2/20 P/E 112× · PEG — 15% evidence | 3.4/20 RS sector -43.7% · RS bench -25.2% · 1Y -54.7%3 of 10 weeks ahead 70% evidence |
| Exact sum: 6.6 + 10.8 + 9.2 + 3.4 = 30 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Embassy Developments LtdEMBDL | 26.2/100Adverse evidence64% evidence | BASING | 5.9/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence | 3.4/25 ROCE -2.4% · OPM -60% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.9/20 RS sector -18.4% · RS bench -15.8% · 1Y -42.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 5.9 + 3.4 + 10 + 6.9 = 26.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28RattanIndia Enterprises LtdRTNINDIA | 17.5/100Adverse evidence74% evidence | ASLEEP | 2.7/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence | 1.0/25 ROCE -4.8% · OPM 2.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.8/20 RS sector -32.1% · RS bench -24.4% · 1Y -55.3%1 of 10 weeks ahead 70% evidence |
| Exact sum: 2.7 + 1 + 10 + 3.8 = 17.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Central Mine Planning & Design Institute LtdCMPDI | 63.2/100Thin evidence · provisional40% evidence | ASLEEP | 22.4/35 Revenue — · PAT — · OPM change 8 pp 34% evidence | 20.6/25 ROCE 38.1% · OPM 30% 100% evidence | 10.2/20 P/E 23.5× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 9 weeks ahead 0% evidence |
| Exact sum: 22.4 + 20.6 + 10.2 + 10 = 63.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30FlySBS Aviation LtdFLYSBS | 57.7/100Thin evidence · provisional41% evidence | BREAKING OUT | 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence | 19.4/25 ROCE 32.5% · OPM 21% 95% evidence | 10.6/20 P/E 20× · PEG — 15% evidence | 12.3/20 RS sector — · RS bench 43.9% · 1Y 14.1%6 of 10 weeks ahead 25% evidence |
| Exact sum: 15.4 + 19.4 + 10.6 + 12.3 = 57.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 31Qualitek Labs Ltd544091 | 54.3/100Thin evidence · provisional29% evidence | BREAKING OUT | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 15.1/25 ROCE 11.9% · OPM 26% 76% evidence | 9.8/20 P/E 44.2× · PEG — 15% evidence | 12.1/20 RS sector — · RS bench 42.7% · 1Y —4 of 6 weeks ahead 25% evidence |
| Exact sum: 17.3 + 15.1 + 9.8 + 12.1 = 54.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Shree Vasu Logistics LtdSVLL | 52.6/100Thin evidence · provisional50% evidence | BREAKING OUT | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence | 16.0/25 ROCE 12.9% · OPM 25.8% 95% evidence | 8.8/20 P/E 126× · PEG — 15% evidence | 9.5/20 RS sector -16.1% · RS bench 17.5% · 1Y 2.2%10 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 16 + 8.8 + 9.5 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Indiqube Spaces LtdINDIQUBE | 49.7/100Thin evidence · provisional49% evidence | BREAKING OUT | 18.9/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence | 9.3/25 ROCE 6.4% · OPM 61% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 11.5/20 RS sector — · RS bench 10.4% · 1Y -11.8%5 of 10 weeks ahead 25% evidence |
| Exact sum: 18.9 + 9.3 + 10 + 11.5 = 49.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Maagh Advertising & Marketing Services Ltd543624 | 49.5/100Thin evidence · provisional35% evidence | 18.4/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 9.1/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.0/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.4 + 9.1 + 10 + 12 = 49.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Tandhan Industries Ltd512062 | 46.3/100Thin evidence · provisional33% evidence | BREAKING OUT | 20.2/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.7/25 ROCE -0.3% · OPM 15.8% 76% evidence | 9.4/20 P/E 71.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —10 of 10 weeks ahead 0% evidence |
| Exact sum: 20.2 + 6.7 + 9.4 + 10 = 46.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Shree Rama Newsprint LtdRAMANEWS | 45.4/100Thin evidence · provisional46% evidence | 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence | 6.1/25 ROCE 1.9% · OPM 8% 71% evidence | 10.0/20 P/E — · PEG — 0% evidence | 15.2/20 RS sector 9.7% · RS bench 10.5% · 1Y 21.7%11 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 14.1 + 6.1 + 10 + 15.2 = 45.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Gulshan Polyols Ltd's share price today?
Gulshan Polyols Ltd trades at ₹175, +8.2% over the past year. The company is valued at ₹1,090 Cr. The stock sits at 55% of its 52-week range of ₹126–₹215, −2.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 21 weeks in. — as of 11 September 2026.
What were Gulshan Polyols Ltd's latest quarterly results?
Gulshan Polyols Ltd reported revenue of ₹640 Cr and net profit of ₹54.0 Cr for the Jun 26 quarter. Revenue rose 7.9% and profit rose 315.4% year on year. Earnings per share were ₹8.58. The operating margin was 13.0%, 7.0 pp higher than a year earlier. — as of 11 September 2026.
What is Gulshan Polyols Ltd's revenue?
Gulshan Polyols Ltd reported revenue of ₹640 Cr in the Jun 26 quarter, +7.9% year on year. For the full FY26 fiscal year, revenue was ₹2,312 Cr (+14.5%). Over the last 10 years revenue compounded at 18.2% a year. — as of 11 September 2026.
What is Gulshan Polyols Ltd's profit?
Gulshan Polyols Ltd earned ₹54.0 Cr of net profit in the Jun 26 quarter, +315.4% year on year — the 7th straight quarter of growth. Full-year FY26 profit was ₹107 Cr. The operating margin ran 13.0% in the latest quarter. — as of 11 September 2026.
What is Gulshan Polyols Ltd's market cap?
Gulshan Polyols Ltd's market capitalisation is ₹1,090 Cr at a share price of ₹175. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is Gulshan Polyols Ltd's P/E ratio?
Gulshan Polyols Ltd trades at a P/E of 7.4×, at the 2nd percentile of its own 11-year range, against a long-run median of 15.8×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does Gulshan Polyols Ltd pay a dividend?
Yes — Gulshan Polyols Ltd's dividend payout was 9% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.
Is Gulshan Polyols Ltd overvalued?
On its own history, Gulshan Polyols Ltd looks cheap: its P/E of 7.4× has been cheaper only 2% of the time in 11 years (long-run median 15.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is Gulshan Polyols Ltd growing?
Yes — Gulshan Polyols Ltd is growing: latest-quarter revenue +7.9% year on year, profit +315.4%, and the margin +7.0 pp at 13.0%. The 10-year compound rates are 18.2% (revenue) and 13.6% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is Gulshan Polyols Ltd performing?
Gulshan Polyols Ltd is in a confirmed uptrend, 21 weeks in. Its latest quarter's revenue rose 7.9% and profit rose 315.4% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is Gulshan Polyols Ltd in?
Improving — EPS growth bottomed 8 quarters ago at −42.0% and has held its recovery at +420.9%, ROCE lifting at 19.0%. The read comes from the last 12 quarters of growth (revenue growth +9.4% latest, profit growth +432.1% latest, eps growth +420.9% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is Gulshan Polyols Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 21 of stage 2), trading −2.1% versus its 200-day average and at 55% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Gulshan Polyols Ltd beating the market?
Not lately — on a trailing-13-week view Gulshan Polyols Ltd is currently behind the NIFTY 500 (7 weeks and counting; last ahead the week of 2026-07-24), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +230% against the NIFTY 500's +259% — behind the index over the full window. — as of 11 September 2026.
Will Gulshan Polyols Ltd's share price go up?
This page publishes no price forecast for Gulshan Polyols Ltd. What it measures instead: the share price is ₹175, the price is in a confirmed uptrend 21 weeks in. Its P/E of 7.4× sits at the 2nd percentile of its own 11-year range. — as of 11 September 2026.
Who owns Gulshan Polyols Ltd?
Promoters hold 66.8% of Gulshan Polyols Ltd, foreign institutions 0.3%, domestic institutions 0.0% and the public 32.6% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.
Does Gulshan Polyols Ltd have too much debt?
It is moderate — Gulshan Polyols Ltd's debt-to-equity is 0.44, and operating profit covers the interest bill 6×. FY26 borrowings were ₹318 Cr against equity of ₹718 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Gulshan Polyols Ltd's capex?
Gulshan Polyols Ltd spent ₹260 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹26.0 Cr, with ₹7.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Gulshan Polyols Ltd's cash flow?
Gulshan Polyols Ltd generated ₹207 Cr of operating cash flow in FY26 and ₹181 Cr of free cash flow after ₹26.0 Cr of capital spending. Reported profit that year was ₹107 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Is Gulshan Polyols Ltd's profit real cash?
Yes — over the last 3 fiscal years, 210% of Gulshan Polyols Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹207 Cr against reported profit of ₹107 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.
Where is Gulshan Polyols Ltd in its business cycle?
Gulshan Polyols Ltd's FY26 operating margin was 10.0%, against a 13-year band of 4.2%–17.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 13.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does Gulshan Polyols Ltd's price assume?
At its price on 13 June 2026, Gulshan Polyols Ltd was priced for profit growth of about 20.8% a year. Profit itself has compounded 13.6% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the Gulshan Polyols Ltd story?
The sharpest disagreement: annual EPS moved +332.7% against a +8.2% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Gulshan Polyols Ltd a stock worth studying right now?
This is not investment advice. The machine read: Gulshan Polyols Ltd is coiled. The quarters are improving, yet the P/E sits at the 2nd percentile of its own 11-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!